Group 1: Epoetin alfa HEXAL is dosed and injected subcutaneously according to the instructions in the summary of product characteristics one to three times per week under close monitoring of the haemo
Sponsors
HEXAL AG, Hexal AG
Conditions
Chemotherapy induced anaemia under anthracycline therapy
D61.10D61.10
Unknown Phase
Epoetin alfa HEXAL® in Chemotherapy induced Anaemia and Evolution of Cardiomyopathy under Anthracyclines - A non-interventional study
Active, not recruitingDRKS00004219
Start: 2012-08-29Target: 400Updated: 2025-04-07
Epoetin alfa HEXAL® in oncology and haematology patients with chemotherapy induced anaemia. A noninterventional observational study.
Active, not recruitingDRKS00005282
Start: 2013-10-08Target: 400Updated: 2025-04-07